News
GlobalData on MSN1mon
SolasCure initiates Phase II trial of chronic wound treatment gelThe patented biomimetic product has Tarumase, a clone of medical maggots’ enzyme that functions by breaking down the fibrin, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback